Genetic Implication of a Novel Thiamine Transporter in Human Hypertension
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objectives We coupled two strategies – trait extremes and genome-wide pooling – to discover a novel BP locus that encodes a previously uncharacterized thiamine transporter. Background Hypertension is a heritable trait that remains the most potent and widespread cardiovascular risk factor, though details of its genetic determination are poorly understood. Methods Representative genomic DNA pools were created from male and female subjects in the highest and lowest 5th %iles of BP in a primary care population of >50,000 individuals. The peak associated SNPs were typed in individual DNA samples, as well as twins/siblings phenotyped for cardiovascular and autonomic traits. Biochemical properties of the associated transporter were evaluated in cellular assays. Results After chip hybridization and calculation of relative allele scores, the peak associations were typed in individual samples, revealing association of hypertension, SBP, and DBP to the previously uncharacterized solute carrier SLC35F3. The BP genetic association at SLC35F3 was validated by meta-analysis in an independent sample from the original source population, as well as the ICBP (across North America and Western Europe). Sequence homology to a putative yeast thiamine (vitamin B1) transporter prompted us to express human SLC35F3 in E. coli, which catalyzed [3H]-thiamine uptake. SLC35F3 risk allele (T/T) homozygotes displayed decreased erythrocyte thiamine content on microbiological assay. In twin pairs, the SLC35F3 risk allele predicted heritable cardiovascular traits previously associated with thiamine deficiency, including elevated cardiac stroke volume with decreased vascular resistance, and elevated pressor responses to environmental (cold) stress. Allelic expression imbalance (AEI) confirmed that cis-variation at the human SLC35F3 locus influenced expression of that gene, and the AEI peak coincided with the hypertension peak. Conclusions Novel strategies were coupled to position a new hypertension susceptibility locus, uncovering a previously unsuspected thiamine transporter whose genetic variants predicted several disturbances in cardiac and autonomic function. The results have implications for the pathogenesis and treatment of systemic hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
The International Consortium for Blood Pressure Genome-Wide Association Studies (2011) · Nature · doi:10.1038/nature10405 · Cited by 2,033
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686 · cited 2×
“Although particular (and relatively uncommon) families display Mendelian cosegregation of hypertension with alterations in renal electrolyte transport (5), heritable BP variation in the population remains largely unaccounted for, despite recent successes in genome-wide association of large population samples (6).”
Genome-wide allele-specific analysis: insights into regulatory variation
Pastinen, T. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2815 · Cited by 291 · cited 2×
“The rationale for the allelic expression imbalance (AEI) approach was detailed by Pastinen (31); briefly, AEI was employed to provide evidence that a cis-quantitative trait locus (QTL) (in particular, a cis-eQTL for mRNA expression) exists at the SLC35F3 locus; that is, the abundance of SLC35F3 transcripts is tested f…”
Self-citationComabella, M., Craig, D. W., Camiña-Tato, M., Morcillo, C., Lopez, C., Navarro, A., Rio, J., BiomarkerMS Study Group, Montalban, X., & Martin, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003490 · Cited by 105 · cited 1×
“Genomic DNA pooling is an effective initial strategy that has been successful in detecting genetic associations in amyotrophic lateral sclerosis (39), memory performance (40), progressive supranuclear palsy (41), multiple sclerosis (42), andmelanoma (43).”
Schork, N. J., Nath, S. K., Fallin, D., & Chakravarti, A. (2000) · The American Journal of Human Genetics · doi:10.1086/321201 · Cited by 86 · cited 2×
“The statistical power of association between bi-allelic DNA markers and human quantitative trait loci can be substantially augmented by the sampling patients from opposite (highest and lowest) ends of the trait distribution (11), and analyses of the quantitative trait in trait-extreme subjects (as opposed to dichotomi…”
Self-citation
Cited by
SLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
The selection landscape and genetic legacy of ancient Eurasians
Irving-Pease, E. K., Refoyo-Martínez, A., Barrie, W., Ingason, A., Pearson, A., Fischer, A., Sjögren, K.-G., Halgren, A. S., Macleod, R., Demeter, F., et al. (2024) · Nature · doi:10.1038/s41586-023-06705-1 · Cited by 126
Self-citationThe oncogene SLC35F2 is a high-specificity transporter for the micronutrients queuine and queuosine
Burtnyak, L., Yuan, Y., Stojek, E., Pan, X., Gunaratne, L., Silveira d’Almeida, G., Fergus, C., Martinelli, M., J. Reed, C., Fernandez, J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2425364122 · Cited by 12
Metadata
- Authors
- Zhang, K., Huentelman, M. J., Rao, F., Sun, E. I., Corneveaux, J. J., Schork, A. J., Wei, Z., Waalen, J., Miramontes-Gonzalez, J. P., Hightower, C. M., Maihofer, A. X., Mahata, M., Pastinen, T., Ehret, G. B., Schork, N. J., Eskin, E., Nievergelt, C. M., Saier, M. H., & O'Connor, D. T.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 63
- Issue
- 15
- Pages
- 1542-1555
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2067455597
- Cited by
- 53
- References
- 5
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.